Boston Scientific Announces Results For Second Quarter 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- US stock futures steady after tech slump; investors focus on Middle East tensions
Boston Scientific (BSX) PT Raised to $47 at Cowen
July 24, 2019 3:34 PM EDTCowen analyst Joshua Jennings raised the price target on Boston Scientific (NYSE: BSX) to $47.00 (from $42.00) while maintaining an Outperform rating.
The analyst commented, "While 2Q organic revenue growth of 6.3% was below the midpoint of guidance for 6%-7%, BSX has a steady flow... More
Boston Scientific (BSX) Tops Q2 EPS by 1c
July 24, 2019 6:32 AM EDTBoston Scientific (NYSE: BSX) reported Q2 EPS of $0.39, $0.01 better than the analyst estimate of $0.38. Revenue for the quarter came in at $2.63 billion versus the consensus estimate of $2.64 billion.
GUIDANCE:
Boston Scientific sees Q3 2019 EPS of $0.37-$0.39, versus the consensus of... More
